← FDA Drug Approvals (Drugs@FDA)

LIVDELZI

NDA · New Drug Application · Sponsor: GILEAD SCIENCES INC · Approved 2024-08-14

Drug application

FDA Application #

NDA217899

Application type

New Drug Application

Brand name

LIVDELZI

Generic name

SELADELPAR LYSINE

Active ingredients

SELADELPAR LYSINE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

GILEAD SCIENCES INC

Manufacturer

Gilead Sciences, Inc

First approval

2024-08-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown